ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

GalNAc-conjugated siRNA targeting the DNAJB1-PRKACA fusion junction in fibrolamellar hepatocellular carcinoma.

Christoph Neumayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.